1. Animal Models of Hepatocellular Carcinoma Prevention
   Ram C. Shankaraiah et al, 2019, Cancers CrossRef
2. Drug repurposing: Metformin’s effect against liver tissue damage in diabetes and prostate cancer model
   Pınar Koroglu Aydın et al, 2022, Journal of Diabetes & Metabolic Disorders CrossRef
3. Metformin delays AKT/c-Met-driven hepatocarcinogenesis by regulating signaling pathways for de novo lipogenesis and ATP generation
   Cong Zhang et al, 2019, Toxicology and Applied Pharmacology CrossRef
4. The Role of AMP-Activated Protein Kinase as a Potential Target of Treatment of Hepatocellular Carcinoma
   Xue Jiang et al, 2019, Cancers CrossRef
5. Survival advantage associated with metformin usage in hepatocellular carcinoma patients with diabetes mellitus receiving radical resection: a propensity score matching analysis
   Cui-Song Luo et al, 2020, European Journal of Gastroenterology & Hepatology CrossRef
6. Targeting AMPK, mTOR and β-Catenin by Combined Metformin and Aspirin Therapy in HCC: An Appraisal in Egyptian HCC Patients
   Doaa Ali Abdelmonsif et al, 2018, Molecular Diagnosis & Therapy CrossRef
7. Mechanistic Insights about Sorafenib-, Valproic Acid- and Metformin-Induced Cell Death in Hepatocellular Carcinoma
   Edgar Xchel Franco-Juárez et al, 2024, International Journal of Molecular Sciences CrossRef
8. The protective effect of 1alpha, 25-dihydroxyvitamin d3 and metformin on liver in type 2 diabetic rats
   Samah Elattar et al, 2017, The Journal of Steroid Biochemistry and Molecular Biology CrossRef
9. Metformin Improves Biochemical and Pathophysiological Changes in Hepatocellular Carcinoma with Pre-Existed Diabetes Mellitus Rats
   Maysa A. Mobasher et al, 2021, Pathogens CrossRef
10. Gene expression, regulation of DEN and HBx induced HCC mice models and comparisons of tumor, para-tumor and normal tissues
    Qin Tang et al, 2017, BMC Cancer CrossRef
11. Recent Insights of Metformin on Hepatocellular Carcinoma (HCC)
    Kaizhen Wang et al, 2023, Mini-Reviews in Medicinal Chemistry CrossRef
12. Re-evaluation of the anticarcinogenic effect of metformin in a chemically-induced hepatocellular carcinoma model not associated with diabetes
    Fatima A. M. El-Deeb et al, 2022, Egyptian Journal of Basic and Applied Sciences CrossRef